CPAP for the Metabolic Syndrome in Patients with Obstructive Sleep Apnea

Abstract

In patients with moderate-to-severe obstructive sleep apnea syndrome, 3 months of CPAP therapy lowers blood pressure and partially reverses metabolic abnormalities. (Funded by Pfizer; ClinicalTrials.gov number, NCT00694616.).